Tower Research Capital LLC (Trc) Bristol Myers Squibb CO Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 59,311 shares of BMY stock, worth $2.79 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
59,311
Previous 123,999
52.17%
Holding current value
$2.79 Million
Previous $7.01 Million
48.42%
% of portfolio
0.11%
Previous 0.14%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,806Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.46 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.08 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.46 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.12 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.9B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...